Literature DB >> 21311680

Curcumin Induces Downregulation of E2F4 Expression and Apoptotic Cell Death in HCT116 Human Colon Cancer Cells; Involvement of Reactive Oxygen Species.

Kyung-Chan Kim1, Chuhee Lee.   

Abstract

E2F transcription factors and their target genes have been known to play an important role in cell growth control. We found that curcumin, a polyphenolic phytochemical isolated from the plant Curcuma longa, markedly suppressed E2F4 expression in HCT116 colon cancer cells. Hydrogen peroxide was also found to decrease E2F4 protein level, indicating the involvement of reactive oxygen species (ROS) in curucmin-induced downregulation of E2F4 expression. Involvement of ROS in E2F4 downregulation in response to curcumin was confirmed by the result that pretreatment of cells with N-acetylcystein (NAC) before exposure of curcumin almost completely blocked the reduction of E2F4 expression at the protein as well as mRNA level. Anti-proliferative effect of curcumin was also suppressed by NAC which is consistent to previous reports showing curcumin-superoxide production and induction of poly (ADP-ribose) polymerase (PARP) cleavage as well as apoptosis. Expression of several genes, cyclin A, p21, and p27, which has been shown to be regulated in E2F4-dependent manner and involved in the cell cycle progression was also affected by curcumin. Moreover, decreased (cyclin A) and increased (p21 and p27) expression of these E2F4 downstream genes by curcumin was restored by pretreatment of cells with NAC and E2F4 overexpression which is induced by doxycycline. In addition, E2F4 overexpression was observed to partially ameliorate curcumin-induced growth inhibition by cell viability assay. Taken together, we found curcumin-induced ROS down-regulation of E2F4 expression and modulation of E2F4 target genes which finally lead to the apoptotic cell death in HCT116 colon cancer cells, suggesting that E2F4 appears to be a novel determinant of curcumin-induced cytotoxicity.

Entities:  

Keywords:  Cell proliferation; Curcumin; E2F4; Reactive oxygen species

Year:  2010        PMID: 21311680      PMCID: PMC3034119          DOI: 10.4196/kjpp.2010.14.6.391

Source DB:  PubMed          Journal:  Korean J Physiol Pharmacol        ISSN: 1226-4512            Impact factor:   2.016


  26 in total

1.  E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

Authors:  H Müller; A P Bracken; R Vernell; M C Moroni; F Christians; E Grassilli; E Prosperini; E Vigo; J D Oliner; K Helin
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins.

Authors:  G Leone; F Nuckolls; S Ishida; M Adams; R Sears; L Jakoi; A Miron; J R Nevins
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region.

Authors:  Y He; M K Armanious; M J Thomas; W D Cress
Journal:  Oncogene       Date:  2000-07-13       Impact factor: 9.867

4.  Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway.

Authors:  Arthur P Young; Rakesh Nagarajan; Gregory D Longmore
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

5.  Genotoxic stress induces expression of E2F4, leading to its association with p130 in prostate carcinoma cells.

Authors:  Erica L DuPree; Suparna Mazumder; Alexandru Almasan
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

Review 6.  Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis.

Authors:  James DeGregori; David G Johnson
Journal:  Curr Mol Med       Date:  2006-11       Impact factor: 2.222

7.  Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1.

Authors:  M Koziczak; W Krek; Y Nagamine
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

8.  Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages.

Authors:  Y Abe; S Hashimoto; T Horie
Journal:  Pharmacol Res       Date:  1999-01       Impact factor: 7.658

9.  Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance.

Authors:  Ricky A Sharma; Stephanie A Euden; Sharon L Platton; Darren N Cooke; Aisha Shafayat; Heather R Hewitt; Timothy H Marczylo; Bruno Morgan; David Hemingway; Simon M Plummer; Munir Pirmohamed; Andreas J Gescher; William P Steward
Journal:  Clin Cancer Res       Date:  2004-10-15       Impact factor: 12.531

10.  Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.

Authors:  Ju-Hyung Woo; Young-Ho Kim; Yun-Jung Choi; Dae-Gon Kim; Kyung-Seop Lee; Jae Hoon Bae; Do Sik Min; Jong-Soo Chang; Yong-Jin Jeong; Young Han Lee; Jong-Wook Park; Taeg Kyu Kwon
Journal:  Carcinogenesis       Date:  2003-05-09       Impact factor: 4.944

View more
  13 in total

1.  GS28 Protects Neuronal Cell Death Induced by Hydrogen Peroxide under Glutathione-Depleted Condition.

Authors:  Hwa Ok Lee; Yu Jeong Byun; Kyung-Ok Cho; Seong Yun Kim; Seong-Beom Lee; Ho-Shik Kim; Oh-Joo Kwon; Seong-Whan Jeong
Journal:  Korean J Physiol Pharmacol       Date:  2011-06-30       Impact factor: 2.016

2.  Involvement of ROS in Curcumin-induced Autophagic Cell Death.

Authors:  Youn Ju Lee; Nam-Yi Kim; Young-Ah Suh; Chuhee Lee
Journal:  Korean J Physiol Pharmacol       Date:  2011-02-28       Impact factor: 2.016

3.  Curcumin suppresses proliferation of colon cancer cells by targeting CDK2.

Authors:  Tae-Gyu Lim; Sung-Young Lee; Zunnan Huang; Do Young Lim; Hanyong Chen; Sung Keun Jung; Ann M Bode; Ki Won Lee; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-02-18

4.  Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature.

Authors:  Bharat Aggarwal; Sahdeo Prasad; Bokyung Sung; Sunil Krishnan; Sushovan Guha
Journal:  Curr Colorectal Cancer Rep       Date:  2013-03-01

5.  Protective effect of butylated hydroxylanisole against hydrogen peroxide-induced apoptosis in primary cultured mouse hepatocytes.

Authors:  Geun Hye Hwang; Yu Jin Jeon; Ho Jae Han; Soo Hyun Park; Kyoung Min Baek; Woochul Chang; Joong Sun Kim; Lark Kyun Kim; You-Mie Lee; Sangkyu Lee; Jong-Sup Bae; Jun-Goo Jee; Min Young Lee
Journal:  J Vet Sci       Date:  2015-03-18       Impact factor: 1.672

6.  The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway.

Authors:  Tao Jia; Li Zhang; Yale Duan; Min Zhang; Gang Wang; Jun Zhang; Zheng Zhao
Journal:  Cancer Cell Int       Date:  2014-11-30       Impact factor: 5.722

7.  Increased HoxB4 Inhibits Apoptotic Cell Death in Pro-B Cells.

Authors:  Sung-Won Park; Kyung-Jong Won; Yong-Soo Lee; Hye Sun Kim; Yu-Kyung Kim; Hyeon-Woo Lee; Bokyung Kim; Byeong Han Lee; Jin-Hoi Kim; Dong-Ku Kim
Journal:  Korean J Physiol Pharmacol       Date:  2012-08-10       Impact factor: 2.016

8.  Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs.

Authors:  Shruti U Gandhy; Kyounghyun Kim; Lesley Larsen; Rhonda J Rosengren; Stephen Safe
Journal:  BMC Cancer       Date:  2012-11-30       Impact factor: 4.430

9.  Anti-Oxidative and Anti-Inflammatory Effects of QGC in Cultured Feline Esophageal Epithelial Cells.

Authors:  Myeong Jae Lee; Hyun Ju Song; Jun Yeong Jeong; Sun Young Park; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2013-02-14       Impact factor: 2.016

10.  Curcumin protects against the intestinal ischemia-reperfusion injury: involvement of the tight junction protein ZO-1 and TNF-α related mechanism.

Authors:  Shuying Tian; Ruixue Guo; Sichen Wei; Yu Kong; Xinliang Wei; Weiwei Wang; Xiaomeng Shi; Hongyu Jiang
Journal:  Korean J Physiol Pharmacol       Date:  2016-02-23       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.